Chromosome Breakage Induced by DEB in Thai Patients with Fanconi Anemia

Authors

  • Somporn Theingtat Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University
  • Wichanun Yamkamol Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University
  • Yodsaward Theptaranon Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University
  • Pimpichaya Patmasiriwat Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University

Keywords:

Chromosome breakage, Fanconi anemia, DEB

Abstract

Abstract: Finding of chromosome breakage is a diagnostic hallmark of Fanconi anemia (FA), a hereditary bone marrow failure syndrome with autosomal recessive inheritance. A defect in DNA repair mechanism leading to genome instability is an important etiology of FA. One strategic methodology to detect instability within chromosomes is a clastagenic introduction into the cell
culture. Since the chromosome breakage analysis among Thai FA patients and standardized condition of the optimum clastagenic concentration used for the test among Thai patients and Thai normal subjects have never been reported, we then initiated this work in order to improve diagnostic accuracy of this rare but important genetic disease. Lymphocytes from patients and their first degree relatives of seven families as well as lymphocytes from thirty normal Thais were cultured using modified standard culture procedure for chromosome preparation. Chromosome breaks were induced by different concentration of a clastagenic agent diepoxybutane (DEB) from 0.0 to 0.2 Mg/mL. Chromosome analysis were determined in the total of 2,400 metaphases from normal control subjects and 1,260 metaphases from FA patients and their family members. Result shows that chromosome breaks were easily observed when induced by low concentration of DEB (0.01 to 0.1 Mg/mL) or even in uninduced culture (spontaneous breaks) in the majority FA patients. Five out of seven FA families exhibited chromosome breakage in various number of chromosomes. In contrast, no chromosome break was detectable in all thirty normal Thai samples eventhough DEB was used at the concentration as high as 0.2 Mg/mL. We propose herein that chromosome breakage analysis is a useful technique and should be performed in all Thai patients suspicious of FA to confirm clinical diagnosis. DEB concentration at 0.1 Mg/mL should be suitable for chromosome breakage analysis for FA in Thai people.

Downloads

Download data is not yet available.

References

Lee GR. Pancytopenia, aplastic anemia and pure red cell aplasia. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer PJ, Rodgers MG, eds. Wintrobe's Clinical Hematology, Volume I. 10 ed. Maryland: Williams & Wilkins 1999:1472-3.

Lynn and Dave Frohnmayer. Fanconi anemia: A Handbook for famillies and Their Physicians. 2" ed. Eugene : Fanconi Anemia Research Fund, Inc., 1995.

Connor MJ, Ferguson-Smith AM. Essential medical genetics: Chromosome Aberrations. 3d ed. London: Blackwell Science 1991.

Sum H, Puto HA. Selected mendelian diseases. In : Nora JJ, Fraser FC, eds. Medical Genetics, principle and practice. 3 ed. Philadelphia : Lee & Febiger 1989:167-8.

Fanconi G : Familial constitutional panmyelocytopathy, Fanconi's anemia (FA). I.Clinical aspects. Semin Hematol 1967;4:233.

Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anemia. Natl Rev Genet 2001;2:446-57.

Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature 19924356:763-7.

Lo Ten Foe JR, et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nature Genet 1996;14:320-3.

de Winter JP, et al. Isolation of a cDNA representing the fanconi anemia complementation group E gene. Am J Hum Genet 2000;67:1306-8.

de Winter JP, et al. The Fanconi anemia gene FANCF encodes a novel protein with homology to ROM. Nature Genet 2000;24:15-6.

de Winter JP. The Fanconi anemia group G gene FANCG is identical with XRCC9. Nature Genet 1998:20:281-3.

Howlett NG, Taniquchi T, OIson S, Cox B, Waisfisz de Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002:297:606-9.

D'Andrea AD, Grompe M. The Fanconi anemia/BRCA pathway. Nature Rev (online) 2003;3:23-34. (www.Nature.Com/reviews/cancer)

Whitney MA, Jakobs P, Kaback M, Moses RE, Grompe M. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at - risk population. Hum Mutat 1994;3:339-41.

Verlander PC, et al. Carrier frequency of the IVS4 +4A-T mutation of the Fanconi anemia gene FAC in the Ashkenazi Jewish population. Blood 1995,86.4034-8

Gillio AP, Verlander PC, Batish SD, Giampietro PF, Auerbach AD. Phenotypic consequences of mutations in the Fanconi anemia FAC gene : an International Fanconi Anemia Registry study. Blood 1997,90:105-10.

Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry : Relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989,73:391.

Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. In: Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE, Seidman JG, Smith DR, eds. Current Protocols in Human Genetics: Current Protocols. New York 1994.

Witt E, Ashworth A. D-Day for BRCA2. Science 2002;297:534.

West SC. Cross-links between Fanconi anemia and BRCA2. DNA Repair 20032:231-4.

MarX J. Debate surges over the origins of genomic defects in cancer. Science 2002;297:544-6.

Gregory RC, Taniguchi T, D'Andrea AD. Regulation of the Fanconi anemia pathway by monoubiquitination. Sem Cancer Biol 2003;13:77-82.

Welcsh PL, Owen KN, King MC. Insights into the functions of BRCA1 and BRCA2 (review). TIG 2000;16:69-74.

Billie RB, Fromcis TF. Basic laboratory techniques in cell culture, U.S. Department of Health and Human Services, 1981:123-4.

Gosden CM, Davidson C, Robertson M. Lymphocyte culture. In: Rooney DE, Czepnlkowaki BH, eds. Human Cytogenetics Volume1 Constitutional analysis: A Practical Approach. New York: Oxford University Press, 1992:30-40.

บังอร ตัณฑ์เกยูร, ทัศนีย์ เล็บนาค และกนกนาถ ชูปัญญา. ปฏิบัติการ Cytogenetics ในทางการแพทย์. กรุงเทพฯ: คณะเทคนิคการแพทย์ มหาวิทยาลัยมหิดล, 2527:17-20.

Alter BP. Fanconi's anemia and malignancies. Am J Hematol 1996;53:99-110.

Ishida R, Buchwald M. Susceptibility of Fanconi's anemia lymphoblasts to DNA cross-linking and alkylating agents. Cancer Res 1982;42:4000-6.

Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973;33:1829-36.

Strathdee CA, Buchwald M. Molecular and cellular biology of Fanconi anemia. Am J Peddiatr Hematol Oncol 1992;14:177-85.

Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: First reportt. In: Schroeder-Kurth T'M, Auerbach AD, Obe G, eds. Fanconi anemia: clinical, cytogenetic, and experimental aspects. Berlin: Springer-Verlag 1989:3-17.

Auerbach AD, Ghosh R, Pollio PC, Zhang M. Diepoxybutane test for prenatal and postnatal diagnosis of Fanconi anemia. In: Schroeder-Kurth T'M, Auerbach AD, Obe G, eds. Fanconi anemia: clinical, cytogenetic, and experimental aspects. Berlin: Springer-Verlag, 1989.71-82.

Downloads

Published

2022-12-30

Issue

Section

นิพนธ์ต้นฉบับ (Original article)